Elucidating the post-DR4 signaling pathways that can potentiate the γ oscillation-enhancing effect of DA, may identify potential targets for cognition-boosting therapies in normal aging and aging-related diseases like Alzheimer’s disease. The gene discussed is TNFRSF10A; the disease is early-onset autosomal dominant Alzheimer disease.